BioNTech SE (BNTX) Analyst Estimates Annual - Discounting Cash Flows
BNTX
BioNTech SE
BNTX (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-30
2021
12-30
2020
12-30
2019
12-30
Number of Analysts 7 8 15 12 13 14 13 6 6 11 6
Estimated Revenue
Low 2,746 2,775 2,455 2,658 3,091 2,564 1,791 12,112 13,209 305.4 84.43
Average 3,843 3,883 3,436 3,269 3,193 2,750 2,507 17,847 19,463 450 124.4
High 5,032 5,086 4,500 4,366 3,388 2,838 3,283 23,275 25,383 586.9 162.2
Estimated EBITDA
Low 854.7 863.8 764.3 827.5 962.1 798 557.6 3,770 4,112 95.08 26.28
Average 1,196 1,209 1,070 1,018 994 855.9 780.4 5,555 6,059 140.1 38.72
High 1,567 1,583 1,401 1,359 1,055 883.3 1,022 7,245 7,901 182.7 50.5
Estimated EBIT
Low 718.7 726.3 642.6 695.8 809 671 468.9 3,170 3,458 79.95 22.1
Average 1,006 1,017 899.4 855.7 835.8 719.7 656.2 4,671 5,095 117.8 32.56
High 1,317 1,331 1,178 1,143 886.7 742.7 859.4 6,092 6,644 153.6 42.46
Estimated Net Income
Low -585.7 -3,031 -3,752 -1,337 -915.1 -1,096 -660.3 4,896 5,054 -531.9 -244.3
Average -417.7 -447.2 -511.7 -411.1 -747 -705.9 -470 8,408 8,680 -381.2 -175.1
High -262.7 556.4 338.1 163.7 -654.5 -315.8 -296.1 11,732 12,111 -222 -101.9
Estimated SGA Expenses
Low 349.9 353.7 312.9 338.8 393.9 326.7 228.3 1,544 1,683 38.93 10.76
Average 489.7 494.9 437.9 416.6 407 350.4 319.5 2,274 2,481 57.35 15.85
High 641.4 648.2 573.5 556.5 431.7 361.6 418.4 2,966 3,235 74.8 20.68
Estimated EPS
Low -2.44 -12.61 -15.61 -5.56 -3.81 -4.56 -2.75 20.36 21.02 -2.21 -1.02
Average -1.74 -1.87 -3.25 -2.32 -3.32 -3.31 -1.96 34.97 36.1 -1.59 -0.728
High -1.09 2.31 1.41 0.681 -2.72 -1.31 -1.23 48.8 50.38 -0.923 -0.424
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program